Pregnancy Exposure Registry for Tysabri®
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Biogen
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Natalizumab for thE Relief of MS Associated FatiGue
- Status
- COMPLETED
- Phase
- N/A
Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS
- Status
- COMPLETED
- Phase
- N/A
BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE2
BIIB014 Phase 2a Monotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)
- Status
- COMPLETED
- Phase
- N/A
Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Rituxan in Churg Strauss Syndrome With Renal Involvement
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study
- Status
- COMPLETED
- Phase
- PHASE1
Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma
- Status
- COMPLETED
- Phase
- NA
Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)
- Status
- TERMINATED
- Phase
- PHASE3